These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7529034)

  • 1. Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals.
    Devico AL; Rahman R; Sarngadharan MG; Veronese FD
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):953-60. PubMed ID: 7529034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
    Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
    J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody.
    Chiba J; Yamaguchi A; Suzuki Y; Nakano M; Zhu W; Ohba H; Saito A; Shinagawa H; Yamakawa Y; Kobayashi T; Kurata T
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2921-9. PubMed ID: 9000082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of HIV-1 reverse transcriptase inhibitory antibodies in the sera of some HTLV-1 carriers and absence of neutralizing antibodies against HIV-1 in the sera of HTLV-1 carriers.
    Inoue M; Sei Y; Kashiwagi S; Shingu T; Yokoyama MM
    J Clin Lab Immunol; 1989 Apr; 28(4):173-7. PubMed ID: 2483412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
    Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxanilide derivative non-nucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic forms of the enzyme.
    Fletcher RS; Syed K; Mithani S; Dmitrienko GI; Parniak MA
    Biochemistry; 1995 Apr; 34(13):4346-53. PubMed ID: 7535561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved assays for DNA-polymerizing enzymes by the use of enzymatically synthesized 5-[125I]iodo-2'-deoxyuridine triphosphate, illustrated by direct quantitation of anti-HIV reverse transcriptase antibody and by serum DNA polymerase analyses.
    Neumüller M; Karlström AR; Källander CF; Gronowitz JS
    Biotechnol Appl Biochem; 1990 Feb; 12(1):34-56. PubMed ID: 1690011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression.
    Grimison B; Laurence J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):58-68. PubMed ID: 7536108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products.
    Ferns RB; Partridge JC; Tisdale M; Hunt N; Tedder RS
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):307-13. PubMed ID: 1712217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
    Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
    Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection.
    Wolfs TF; Geelen JL; Schellekens H; Barin F; Dekker JT; Goudsmit J
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):535-40. PubMed ID: 2480153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assays for the measurement of human immunodeficiency virus, type 1 reverse transcriptase antigen and antibodies.
    Loveday C; Tedder RS
    J Virol Methods; 1993 Feb; 41(2):181-92. PubMed ID: 7684387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of heat inactivation of reverse transcriptase of human immunodeficiency virus type 1 by seropositive sera.
    Nagumo T; Takeuchi Y; Hoshino H
    Jpn J Cancer Res; 1992 Jun; 83(6):594-600. PubMed ID: 1379577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment.
    Gargano N; Cattaneo A
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2591-9. PubMed ID: 9349480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 reverse transcriptase inhibiting antibody titer in serum: relation to disease progression and to core-antibody levels.
    Neumüller M; Karlsson A; Lennerstrand J; Källander CF; Sandström E; Holmberg V; Gronowitz JS
    J Med Virol; 1992 Apr; 36(4):283-91. PubMed ID: 1374456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.
    Neumüller M; Karlsson A; Lennerstrand J; Källander CF; Holmberg V; Långström-Persson U; Thorstensson R; Sandström E; Gronowitz JS
    J Med Virol; 1991 May; 34(1):55-63. PubMed ID: 1715898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
    Debyser Z; De Vreese K; Knops-Gerrits PP; Baekelandt V; Bhikhabhai R; Strandberg B; Pauwels R; Anné J; Desmyter J; De Clercq E
    Mol Pharmacol; 1993 Apr; 43(4):521-6. PubMed ID: 7682649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
    Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
    Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral discrimination of enantiomeric 2'-deoxythymidine 5'-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases.
    Yamaguchi T; Iwanami N; Shudo K; Saneyoshi M
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1023-7. PubMed ID: 7513992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.